Seytri S 500mg/250mg Injection
Marketer
Hauz Pharma Pvt Ltd
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Seytri S 500mg/250mg Injection
Combiflox 500mg/250mg Injection is a dual-action antibiotic, indicated for treating diverse bacterial infections. Its mechanism combats microbial proliferation, curbing infection spread. Administration must always be under a physician's direct oversight; strict adherence to the prescribed dosage schedule is crucial. Complete the entire treatment course, regardless of symptom improvement; premature cessation may compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or worsening side effects necessitate immediate medical attention. Seek immediate medical assistance for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor of all current medications before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration will aid recovery. Your doctor may order blood tests and other diagnostic procedures to monitor treatment response.
Primary Ingredients of Seytri S 500mg/250mg Injection
There is no text provided to rephrase.
Uses of Seytri S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Seytri S 500mg/250mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Seytri S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Seytri S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Seytri S 500mg/250mg Injection works:
Seytri S Injection (500mg/250mg) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam's role is to counteract bacterial resistance mechanisms, thereby boosting Ceftriaxone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and Seytri S 500mg/250mg Injection.
PregnancySAFE IF PRESCRIBED
Administration of Seytri S 500mg/250mg Injection during gestation is typically deemed safe. Preclinical trials in animals revealed minimal or absent negative impacts on fetal development; nevertheless, clinical data from human subjects are scarce.
Breast feedingCAUTION
The administration of Seytri S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding is advised against until the maternal treatment concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
Administering Seytri S 500mg/250mg Injection might induce drowsiness, blurred vision, or dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Seytri S 500mg/250mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
The 500mg/250mg Seytri S Injection requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Seek medical advice. Dosage changes for the 500mg/250mg Seytri S Injection are not advised for patients experiencing mild to moderate liver dysfunction.
What if you forget to take Seytri S 500mg/250mg Injection :
Omit a Seytri S 500mg/250mg Injection dose? Seek medical advice immediately.
Facts to Know About Seytri S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently